ORCHARD PARK, New York, Sept. 7 -- Oncotarget, a peer-reviewed journal that says it encompasses all molecules, pathways, cellular functions, cell types and even tissues that can be viewed as targets relevant to cancer as well as other diseases, published research articles on the following topics in its Vol. 12, No. 18 edition:

Research Papers:

* Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast ca . . .

Click here for more information about our products